Detalhe da pesquisa
1.
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients.
Int J Cancer
; 154(10): 1794-1801, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38312102
2.
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.
Br J Cancer
; 129(2): 309-317, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237172
3.
Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
Ann Surg Oncol
; 30(3): 1354-1363, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36622529
4.
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 23(1): 77-90, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914889
5.
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study.
Lancet Oncol
; 23(12): 1558-1570, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400106
6.
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade.
Br J Cancer
; 126(4): 569-575, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34621044
7.
Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child-Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial.
BMC Cancer
; 22(1): 377, 2022 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35397508
8.
CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis.
J Hepatol
; 75(3): 600-609, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051329
9.
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
N Engl J Med
; 379(1): 54-63, 2018 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29972759
10.
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Oncol
; 21(6): 796-807, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32416072
11.
Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma.
J Hepatol
; 72(2): 320-341, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31954495
12.
Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma.
J Hepatol
; 73(6): 1460-1469, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32710922
13.
Phase II Trial of Neoadjuvant Bevacizumab with Modified FOLFOX7 in Patients with Stage II and III Rectal Cancer.
Oncologist
; 25(12): e1879-e1885, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32649004
14.
Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI-110) in Hepatocellular Carcinoma.
Hepatology
; 68(4): 1412-1428, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29774579
15.
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.
Lancet
; 389(10088): 2492-2502, 2017 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28434648
16.
ASO Visual Abstract: Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers - Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
Ann Surg Oncol
; 30(3): 1364-1365, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36542251
17.
A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors.
Invest New Drugs
; 36(5): 836-847, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29333575
18.
A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours.
Invest New Drugs
; 36(6): 1026-1036, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29637471
19.
A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma.
Oncology
; 94(6): 329-339, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29719302
20.
Liver Cancer Immunity.
Hepatology
; 73 Suppl 1: 86-103, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32516437